Cargando…
Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
The progressive nature of type 2 diabetes necessitates that treatment is intensified as the disease advances. Several studies have shown that basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) can be used in combination to successfully improve glycemic control and this combinatio...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894076/ https://www.ncbi.nlm.nih.gov/pubmed/27335581 http://dx.doi.org/10.1586/17446651.2016.1113129 |